These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 26799634)

  • 1. De Novo Design of Skin-Penetrating Peptides for Enhanced Transdermal Delivery of Peptide Drugs.
    Menegatti S; Zakrewsky M; Kumar S; De Oliveira JS; Muraski JA; Mitragotri S
    Adv Healthc Mater; 2016 Mar; 5(5):602-9. PubMed ID: 26799634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptides as skin penetration enhancers: mechanisms of action.
    Kumar S; Zakrewsky M; Chen M; Menegatti S; Muraski JA; Mitragotri S
    J Control Release; 2015 Feb; 199():168-78. PubMed ID: 25499919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-penetrating peptides as a novel transdermal drug delivery system.
    Nasrollahi SA; Taghibiglou C; Azizi E; Farboud ES
    Chem Biol Drug Des; 2012 Nov; 80(5):639-46. PubMed ID: 22846609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The transdermal inhibition of melanogenesis by a cell-membrane-permeable peptide delivery system based on poly-arginine.
    Ookubo N; Michiue H; Kitamatsu M; Kamamura M; Nishiki T; Ohmori I; Matsui H
    Biomaterials; 2014 May; 35(15):4508-16. PubMed ID: 24602570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical delivery of Cyclosporine A into the skin using SPACE-peptide.
    Chen M; Kumar S; Anselmo AC; Gupta V; Slee DH; Muraski JA; Mitragotri S
    J Control Release; 2015 Feb; 199():190-7. PubMed ID: 25481447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Permeation enhancer strategies in transdermal drug delivery.
    Marwah H; Garg T; Goyal AK; Rath G
    Drug Deliv; 2016; 23(2):564-78. PubMed ID: 25006687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential of peptide-based enhancers for transdermal delivery.
    Lopes LB; Carvalho VF; de Lemos DP
    Curr Pharm Des; 2015; 21(20):2814-22. PubMed ID: 25925116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural products as potential drug permeation enhancer in transdermal drug delivery system.
    Patil UK; Saraogi R
    Arch Dermatol Res; 2014 Jul; 306(5):419-26. PubMed ID: 24481830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical Penetration Enhancers for Transdermal Drug Delivery - Success and Challenges.
    Ita KB
    Curr Drug Deliv; 2015; 12(6):645-51. PubMed ID: 26239423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of transdermal penetration enhancers by high-throughput screening.
    Karande P; Jain A; Mitragotri S
    Nat Biotechnol; 2004 Feb; 22(2):192-7. PubMed ID: 14704682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in transdermal drug delivery.
    Subedi RK; Oh SY; Chun MK; Choi HK
    Arch Pharm Res; 2010 Mar; 33(3):339-51. PubMed ID: 20361297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Permeation enhancers compatible with transdermal drug delivery systems: part II: system design considerations.
    Pfister WR; Hsieh DS
    Med Device Technol; 1990; 1(6):28-33. PubMed ID: 10171149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dermal peptide delivery using colloidal carrier systems.
    Goebel A; Neubert RH
    Skin Pharmacol Physiol; 2008; 21(1):3-9. PubMed ID: 17912018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transdermal therapeutic systems].
    Losenkova SO
    Eksp Klin Farmakol; 2008; 71(6):54-7. PubMed ID: 19140519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Permeation enhancers compatible with transdermal drug delivery systems. Part I: selection and formulation considerations.
    Pfister WR; Hsieh DS
    Med Device Technol; 1990; 1(5):48-55. PubMed ID: 10171148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced transdermal peptide delivery and stability by lipid conjugation: epidermal permeation, stereoselectivity and mechanistic insights.
    Namjoshi S; Toth I; Blanchfield JT; Trotter N; Mancera RL; Benson HA
    Pharm Res; 2014 Dec; 31(12):3304-12. PubMed ID: 24842663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-Penetrating Peptides as Passive Permeation Enhancers for Transdermal Drug Delivery.
    Chablani L; Singh V
    AAPS PharmSciTech; 2022 Sep; 23(7):266. PubMed ID: 36163537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An unexpected cell-penetrating peptide from Bothrops jararaca venom identified through a novel size exclusion chromatography screening.
    Sciani JM; Vigerelli H; Costa AS; Câmara DA; Junior PL; Pimenta DC
    J Pept Sci; 2017 Jan; 23(1):68-76. PubMed ID: 28054409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of electronic-neutral penetrating peptides cyclosporin A to deliver pro-apoptotic peptide: A possibly better choice than positively charged TAT.
    Gao W; Yang X; Lin Z; He B; Mei D; Wang D; Zhang H; Zhang H; Dai W; Wang X; Zhang Q
    J Control Release; 2017 Sep; 261():174-186. PubMed ID: 28662902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in peptides for enhancing transdermal macromolecular drug delivery.
    Ruan R; Chen M; Zou L; Wei P; Liu J; Ding W; Wen L
    Ther Deliv; 2016; 7(2):89-100. PubMed ID: 26769200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.